Changes in Smoking Habits in Potential Lung Transplant (LTx) Candidates

Abstract

For COPD patients, 519/2359 (22.0%) remained on the WL, 844/2359 (35.8%) had SLT, and 996/2359 (42.2%) had DLT, with 5-year OS of 48.4%, 50.6%, and 57.1% respectively. Again, the highest cumulative number of QALYs and lowest cost per QALY for COPD patients was obtained with exclusive allocation to DLT. Conclusion: From a societal and payer's perspective, exclusive allocation to DLT increased overall QALYs and provided a lower cost per QALY. This is likely due to the substantial increase in mean utility values for DLT recipients, and improved 5-year overall survival.